{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T03:53:34Z","timestamp":1788666814942,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Liaoning Province Science and Technology Plan Joint Program","award":["2023-MSLH-391"],"award-info":[{"award-number":["2023-MSLH-391"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s12035-025-04744-5","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T14:40:46Z","timestamp":1739284846000},"page":"7738-7746","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Serum Inflammatory Factors Levels and Risk of Myasthenia Gravis: A Bidirectional Mendelian Randomization Study"],"prefix":"10.1007","volume":"62","author":[{"given":"Sun","family":"Jingjing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huo","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"issue":"6","key":"4744_CR1","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1007\/s00415-021-10891-1","volume":"269","author":"S Lehnerer","year":"2022","unstructured":"Lehnerer S et al (2022) Burden of disease in myasthenia gravis: taking the patient\u2019s perspective. J Neurol 269(6):3050\u20133063","journal-title":"J Neurol"},{"key":"4744_CR2","doi-asserted-by":"publisher","first-page":"120268","DOI":"10.1016\/j.jns.2022.120268","volume":"437","author":"D Gelinas","year":"2022","unstructured":"Gelinas D et al (2022) The humanistic burden of myasthenia gravis: a systematic literature review. J Neurol Sci 437:120268","journal-title":"J Neurol Sci"},{"key":"4744_CR3","doi-asserted-by":"publisher","first-page":"e16180","DOI":"10.1111\/ene.16180","volume":"31","author":"F Sacca","year":"2023","unstructured":"Sacca F et al (2023) Refocusing generalized myasthenia gravis: patient burden, disease profiles, and the role of evolving therapy. Eur J Neurol 31:e16180","journal-title":"Eur J Neurol"},{"issue":"1","key":"4744_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41572-019-0079-y","volume":"5","author":"NE Gilhus","year":"2019","unstructured":"Gilhus NE et al (2019) Myasthenia gravis. Nat Rev Dis Primers 5(1):30","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"4744_CR5","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/s12883-019-1573-2","volume":"19","author":"ED Bacci","year":"2019","unstructured":"Bacci ED et al (2019) Understanding side effects of therapy for myasthenia gravis and their impact on daily life. BMC Neurol 19(1):335","journal-title":"BMC Neurol"},{"issue":"3","key":"4744_CR6","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.nmd.2020.12.004","volume":"31","author":"NE Gilhus","year":"2021","unstructured":"Gilhus NE (2021) Physical training and exercise in myasthenia gravis. Neuromuscul Disord 31(3):169\u2013173","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"4744_CR7","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S1474-4422(21)00297-0","volume":"21","author":"AR Punga","year":"2022","unstructured":"Punga AR et al (2022) Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders. Lancet Neurol 21(2):176\u2013188","journal-title":"Lancet Neurol"},{"issue":"3","key":"4744_CR8","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/mus.25068","volume":"54","author":"E Santos","year":"2016","unstructured":"Santos E et al (2016) Epidemiology of myasthenia gravis in Northern Portugal: frequency estimates and clinical epidemiological distribution of cases. Muscle Nerve 54(3):413\u2013421","journal-title":"Muscle Nerve"},{"issue":"3","key":"4744_CR9","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/ene.13535","volume":"25","author":"A Zieda","year":"2018","unstructured":"Zieda A et al (2018) A nationwide epidemiological study of myasthenia gravis in Latvia. Eur J Neurol 25(3):519\u2013526","journal-title":"Eur J Neurol"},{"key":"4744_CR10","doi-asserted-by":"crossref","unstructured":"Sobieszczuk E et al (2021) Myasthenia gravis in Poland: National healthcare database epidemiological study. Neuroepidemiology 1\u20138","DOI":"10.1159\/000512973"},{"issue":"10","key":"4744_CR11","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1007\/s00415-018-8995-4","volume":"265","author":"TM Alekseeva","year":"2018","unstructured":"Alekseeva TM et al (2018) Fatigue in patients with myasthenia gravis. J Neurol 265(10):2312\u20132321","journal-title":"J Neurol"},{"key":"4744_CR12","doi-asserted-by":"publisher","first-page":"1110499","DOI":"10.3389\/fimmu.2023.1110499","volume":"14","author":"R Huda","year":"2023","unstructured":"Huda R (2023) Inflammation and autoimmune myasthenia gravis. Front Immunol 14:1110499","journal-title":"Front Immunol"},{"issue":"51","key":"4744_CR13","doi-asserted-by":"publisher","first-page":"32195","DOI":"10.1073\/pnas.2022901117","volume":"117","author":"RP Lisak","year":"2020","unstructured":"Lisak RP, Richman DP (2020) Thymectomy and myasthenia gravis. Proc Natl Acad Sci U S A 117(51):32195\u201332196","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"4744_CR14","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11910-016-0668-z","volume":"16","author":"RL Hurst","year":"2016","unstructured":"Hurst RL, Gooch CL (2016) Muscle-specific receptor tyrosine kinase (MuSK) myasthenia gravis. Curr Neurol Neurosci Rep 16(7):61","journal-title":"Curr Neurol Neurosci Rep"},{"key":"4744_CR15","doi-asserted-by":"publisher","first-page":"25886","DOI":"10.1038\/srep25886","volume":"6","author":"A Uzawa","year":"2016","unstructured":"Uzawa A et al (2016) Changes in inflammatory cytokine networks in myasthenia gravis. Sci Rep 6:25886","journal-title":"Sci Rep"},{"issue":"3","key":"4744_CR16","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/cei.13546","volume":"203","author":"A Uzawa","year":"2021","unstructured":"Uzawa A et al (2021) Roles of cytokines and T cells in the pathogenesis of myasthenia gravis. Clin Exp Immunol 203(3):366\u2013374","journal-title":"Clin Exp Immunol"},{"issue":"19","key":"4744_CR17","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1001\/jama.2017.17219","volume":"318","author":"CA Emdin","year":"2017","unstructured":"Emdin CA, Khera AV, Kathiresan S (2017) Mendelian randomization. JAMA 318(19):1925\u20131926","journal-title":"JAMA"},{"key":"4744_CR18","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s43586-021-00092-5","volume":"2","author":"E Sanderson","year":"2022","unstructured":"Sanderson E, Glymour MM, Holmes MV et al (2022) Mendelian randomization. Nat Rev Methods Primers 2:6. https:\/\/doi.org\/10.1038\/s43586-021-00092-5","journal-title":"Nat Rev Methods Primers"},{"issue":"7944","key":"4744_CR19","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki MI et al (2023) FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 613(7944):508\u2013518","journal-title":"Nature"},{"issue":"7982","key":"4744_CR20","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622","author":"BB Sun","year":"2023","unstructured":"Sun BB et al (2023) Plasma proteomic associations with genetics and health in the UK Biobank. Nature 622(7982):329\u2013338","journal-title":"Nature"},{"key":"4744_CR21","doi-asserted-by":"publisher","unstructured":"Elsworth BL, Mitchell R, Raistrick CA, Paternoster L, Hemani G, Gaunt TR (2017) MRC IEU UK Biobank GWAS pipeline version 1. https:\/\/doi.org\/10.5523\/bris.2fahpksont1zi26xosyamqo8rr","DOI":"10.5523\/bris.2fahpksont1zi26xosyamqo8rr"},{"issue":"8","key":"4744_CR22","doi-asserted-by":"publisher","first-page":"151542","DOI":"10.1016\/j.ijmm.2021.151542","volume":"311","author":"A Magrys","year":"2021","unstructured":"Magrys A, Bogut A (2021) MicroRNA hsa-let-7a facilitates staphylococcal small colony variants survival in the THP-1 macrophages by reshaping inflammatory responses. Int J Med Microbiol 311(8):151542","journal-title":"Int J Med Microbiol"},{"key":"4744_CR23","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.molimm.2021.12.009","volume":"141","author":"A Nadeem","year":"2022","unstructured":"Nadeem A et al (2022) Imbalance in pro-inflammatory and anti-inflammatory cytokines milieu in B cells of children with autism. Mol Immunol 141:297\u2013304","journal-title":"Mol Immunol"},{"key":"4744_CR24","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3389\/fncel.2018.00458","volume":"12","author":"AR Burmeister","year":"2018","unstructured":"Burmeister AR, Marriott I (2018) The interleukin-10 family of cytokines and their role in the CNS. Front Cell Neurosci 12:458","journal-title":"Front Cell Neurosci"},{"issue":"29","key":"4744_CR25","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.1200\/JCO.2016.69.6435","volume":"34","author":"H Zhang","year":"2016","unstructured":"Zhang H et al (2016) Interleukin-10: an immune-activating cytokine in cancer immunotherapy. J Clin Oncol 34(29):3576\u20133578","journal-title":"J Clin Oncol"},{"key":"4744_CR26","doi-asserted-by":"publisher","first-page":"108788","DOI":"10.1016\/j.abb.2021.108788","volume":"701","author":"ML Paz","year":"2021","unstructured":"Paz ML, Barrantes FJ (2021) Cholesterol in myasthenia gravis. Arch Biochem Biophys 701:108788","journal-title":"Arch Biochem Biophys"},{"key":"4744_CR27","doi-asserted-by":"publisher","first-page":"917","DOI":"10.3389\/fimmu.2020.00917","volume":"11","author":"K Albazli","year":"2020","unstructured":"Albazli K, Kaminski HJ, Howard JF Jr (2020) Complement inhibitor therapy for myasthenia gravis. Front Immunol 11:917","journal-title":"Front Immunol"},{"issue":"5","key":"4744_CR28","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1021\/acschemneuro.9b00041","volume":"10","author":"ML Paz","year":"2019","unstructured":"Paz ML, Barrantes FJ (2019) Autoimmune attack of the neuromuscular junction in myasthenia gravis: nicotinic acetylcholine receptors and other targets. ACS Chem Neurosci 10(5):2186\u20132194","journal-title":"ACS Chem Neurosci"},{"issue":"9","key":"4744_CR29","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00011-019-01261-9","volume":"68","author":"IS Hansen","year":"2019","unstructured":"Hansen IS et al (2019) ER stress abrogates the immunosuppressive effect of IL-10 on human macrophages through inhibition of STAT3 activation. Inflamm Res 68(9):775\u2013785","journal-title":"Inflamm Res"},{"key":"4744_CR30","doi-asserted-by":"publisher","first-page":"9704327","DOI":"10.1155\/2020\/9704327","volume":"2020","author":"YQ Chen","year":"2020","unstructured":"Chen YQ et al (2020) Progranulin improves acute lung injury through regulating the differentiation of regulatory T cells and interleukin-10 immunomodulation to promote macrophage polarization. Mediators Inflamm 2020:9704327","journal-title":"Mediators Inflamm"},{"key":"4744_CR31","doi-asserted-by":"publisher","first-page":"8883962","DOI":"10.1155\/2021\/8883962","volume":"2021","author":"K Xie","year":"2021","unstructured":"Xie K et al (2021) Luteolin regulates the differentiation of regulatory T cells and activates IL-10-dependent macrophage polarization against acute lung injury. J Immunol Res 2021:8883962","journal-title":"J Immunol Res"},{"issue":"1","key":"4744_CR32","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/jcm6010012","volume":"6","author":"A Ray","year":"2017","unstructured":"Ray A, Dittel BN (2017) Mechanisms of regulatory B cell function in autoimmune and inflammatory diseases beyond IL-10. J Clin Med 6(1):12","journal-title":"J Clin Med"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04744-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-04744-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04744-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T03:44:17Z","timestamp":1747194257000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-04744-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,11]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["4744"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-04744-5","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,11]]},"assertion":[{"value":"3 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}